Nutrition Claims vs Health Claims on Food Supplements in Saudi Arabia: What SFDA Lets You Say (and What Turns Your Product Into a Drug)

Nutrition claim vs health claim — what's the difference?

The two are governed together by SFDA.FD 2333 (Nutrition and Health Claims) but do different jobs:

• A nutrition claim says something about the product's composition — the level of energy, a nutrient, or a substance. It splits into content claims ("source of," "high in," "low," "free of") and comparative claims ("reduced," "more than," "less than" a reference food). A nutrition claim makes no promise about health outcomes.
• A health claim says something about the relationship between a substance and the body — a function claim (the nutrient's role in normal growth, development, or function) or a risk-reduction claim (the substance reduces a recognised risk factor for disease). It never claims to treat or prevent the disease itself.

The distinction matters because the two families have different evidence and labelling requirements, and because health claims sit one step closer to the line that separates a food from a medicine.

Standard inspected

Table 1 (permitted health claims) and Table 2 (permitted nutrition claims) were read directly in SFDA.FD 2333:2020. We state the rule and give representative examples; we do not reproduce the full protected table text. Verify the exact wording and conditions of any specific claim against the live standard before use.

What SFDA permits: the closed list (Table 1 and Table 2)

SFDA.FD 2333 does not let a brand invent its own wording. Clause 6 sets out the permitted claims:

• Permitted health claims are listed in Table 1. A health claim may appear on a prepackaged food's label and in its advertising only if it is in Table 1 and the product satisfies that claim's conditions of use, including any required cautions (cl. 6.1–6.2).
• Permitted nutrition claims are listed in Table 2 (e.g. "source of" a named nutrient, with the qualifying amount).
• Wording flexibility, same meaning. The presentation of a claim (including graphics and symbols) may vary, but it must carry the same meaning as the entry in Table 1 or Table 2, be truthful and clear, and not mislead (cl. 6.3).
• Default is "not allowed." Clause 6.4 prohibits placing any claim on a food label unless it complies with the approved specification. If it isn't on the list and doesn't meet the conditions, it can't go on the pack.

If a company has evidence for a claim that isn't on the lists, SFDA operates a separate route: an application to the Health & Nutrition Claim Committee (HNCC) with the scientific dossier, evaluated case by case. That is a submission-and-review process, not a self-declared claim.

The disease-claim ban (clause 5.4) — and why it reclassifies your product

SFDA.FD 2333 clause 5 lists the claims that are not permitted on foods at all. Clause 5.4 is the decisive one for supplements: a claim that the food can prevent, reduce the severity of, or treat a disease, disorder, or a particular physiological condition is prohibited. The same clause-5 list also bans, among others:

• claims about the rate or amount of weight loss (cl. 5.1);
• claims citing the advice of doctors or health professionals (cl. 5.2);
• claims that health could be harmed by not eating the food (cl. 5.3);
• unverifiable claims (cl. 5.7); and vague "good-health" words like "beneficial," "healthy," "wholesome" used as claims (cl. 5.10).

Clause 5.4 is not just a labelling foul — it is a classification event. A treatment, prevention or disease claim takes the product out of the food-supplement route and triggers reclassification under SFDA's Products Classification Guidance. The resulting category may be a Health Product or a Human Pharmaceutical Product depending on the product's composition, dose, ingredients, intended purpose and the applicable SFDA classification criteria — the claim alone does not settle which, and the full criteria in the current Guidance decide it. In other words, the claim you print can silently re-decide which standard and which registration pathway your product answers to. This is the labelling-side companion to the dose-based test explained in the food-supplement classification guide: both a disease claim and a total daily dose above the SFDA.FD 55:2023 limit independently push a product out of the food-supplement category.

Practitioner note

The most expensive version of this mistake is a product built, tested, and labelled as a supplement whose marketing copy — often written by a separate team — makes a treatment claim. SFDA sees one product; if the words say "medicine," the food file is the wrong file. Settle claims before artwork and campaign copy are finalised.

Nutrition-content claims and the nutrition panel (GSO 2233)

A nutrition content claim ("source of," "high in," "low," "free of") is only true if the numbers on the pack support it — so it is anchored to the nutrition declaration. That panel is set by GSO 2233 (Requirements of Nutritional Labeling), the same standard that carries the reference-intake (%DV) statement based on a 2,000-kcal diet. Practically:

• The qualifying amount for a content claim is measured against the declared value in the nutrition panel.
• The panel, the Certificate of Analysis, and the registered product data must all agree — a "high in fibre" claim with a fibre figure the CoA can't support is a rejection waiting to happen.
• Edition watch: the current Gulf edition is GSO 2233:2025 (Ed.3, approved 30 April 2025), adopted by SFDA as SFDA.FD/GSO 2233:2025; the English translation was still in public consultation in mid-2026. Confirm the operative Saudi edition and its effective date at submission. See the nutrition-panel and label basics guide for the full declaration.

Claims must match across pack, product page, marketplace, and ads

SFDA.FD 2333 governs claims on labels and in advertising alike — the rule doesn't stop at the physical pack. A claim that is compliant on the carton but embellished on the brand's website, an Amazon/Noon listing, or a social ad is still a violation, and it undermines the registration. Treat the most aggressive claim anywhere in your channels as the one SFDA will judge you by. Keep a single approved claims set and apply it identically to:

• the printed label/artwork (Arabic mandatory under GSO 9);
• the product detail page on your own site;
• marketplace listings (where the seller, not the brand, often writes copy);
• paid and organic ads.

Note also that registration is not advertising permission — food advertising can carry its own SFDA approval requirements. The SFDA vs GSO explainer covers how the national and Gulf layers interact.

Common claim mistakes that trigger rejection

In Mayar Vision's experience (an experience-based list, not an SFDA statistic):

• Treatment/prevention language — "supports immunity against infections," "helps prevent osteoporosis," "relieves anxiety" — i.e. clause 5.4 violations dressed as wellness copy.
• Off-list health claims — a plausible-sounding function claim that simply isn't in Table 1, used without an HNCC approval.
• Content claims the panel can't support — "high in" / "source of" without the qualifying amount in the GSO 2233 declaration.
• Weight-loss rate/amount claims (cl. 5.1) and doctor-endorsement claims (cl. 5.2).
• Vague "healthy/beneficial" wording used as a standalone claim (cl. 5.10).
• Channel drift — compliant pack, non-compliant website or marketplace listing.
• Structure/function slippage — starting from a permitted function claim and "improving" the wording until it implies disease treatment.

How Mayar Vision helps

Mayar Vision reviews a supplement's intended claims against SFDA.FD 2333 — mapping each proposed claim to Table 1 or Table 2 (or flagging it for the HNCC route or removal), checking that content claims are supported by the nutrition declaration and CoA, and screening the full claim set for clause-5 breaches before artwork is printed and campaigns go live.

Planning claims for a supplement bound for Saudi Arabia? Send us your product, full formulation with per-serving amounts, the exact claims you intend to make (label and marketing), and your current artwork, and we'll map which claims are permitted, which need rewording, and which would reclassify the product.

Regulatory notice

This guide provides general regulatory information based on public sources and a direct inspection of SFDA.FD 2333:2020 checked on 9 August 2026. It is not legal advice, an SFDA decision, or a substitute for verifying the current edition of each standard, the exact permitted-claim wording, and product-specific classification before submission or printing artwork. Standards change; confirm the current position first.